Clinical Trial Update: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

View source ↗

Summary

A completed clinical trial update evaluating whether pre-diagnosis use of GLP-1 receptor agonists is associated with post-cancer mortality in adults with obesit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• BYETTA (Exenatide)
• Bydureon (exenatide)
• Lyxumia (lixisenatide)
• OZEMPIC (semaglutide)
• Rybelsus (semaglutide)
• TRULICITY (DULAGLUTIDE)
• Tanzeum (Albiglutide)
• Victoza (Liraglutide)

Snippet

Sponsor: Chung Shan Medical University | Conditions: Obesity & Overweight, Diabetes Mellitus Type 2 | Status: COMPLETED